National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 3536 [05-1270]

Download as PDF 3536 Federal Register / Vol. 70, No. 15 / Tuesday, January 25, 2005 / Notices and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, NHLBI–HR–05–04, ARDs Network Contract. Date: February 3, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: Hyatt Regency Baltimore, 300 Light Street, Baltimore, MD 21202. Contact Person: Valerie L. Prenger, PhD., Review Branch, Room 7194, Division of Extramural Affairs, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, MSC 7924, Bethesda, MD 20892–7924, (301) 435–0288. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: January 14, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–1271 Filed 1–24–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Integrated Preclinical/ Clinical AIDS Vaccine Development (PCAVD). VerDate jul<14>2003 13:14 Jan 24, 2005 Jkt 205001 Date: February 10–11, 2005. Time: 8:30 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: B. Duane Price, PhD., Scientific Review Administrator, Scientific Review Program, National Institute of Allergy & Infectious Diseases, DEA/NIH/DHHS, 6700B Rockledge Drive, Room 3147, Bethesda, MD 20892, (301) 451–2592, dbprice@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Review of an Unsolicited P01. Date: February 17, 2005. Time: 11 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Thomas J. Hiltke, PhD., Scientific Review Administrator, Scientific Review Program, Divison of Extramural Activities, National Institutes of Health/ NIAID, 6700 B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, (301) 496–2550, thiltke@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, International Clinical Sciences Support. Date: February 18, 2005. Time: 9 a.m. to 6 p.m. Agenda: To review and evaluate contract proposals. Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA 22209. Contact Person: Marc L. Lesnick, PhD., Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, DHHS/National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, (301) 496– 2550, ml436d@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Name of Committee: National Institute on Deafness and Other Communications Disorders Special Emphasis Panel, Small Grant Program. Date: March 2, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Shiguang Yang, PhD., Scientific Review Administrator, Division of Extramural Activities, NIDCD, NIH, 6120 Executive Blvd., Bethesda, MD 20892, 301– 496–8683. Name of Committee: National Institute on Deafness and Other Communications Disorders Special Emphasis Panel, NIDCD Training Grants Review. Date: March 8, 2005. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6120 Executive Blvd., Rockville, MD 20852, (Telephone Conference Call). Contact Person: Sheo Singh, PhD., Scientific Review Administrator, Scientific Review Branch, Division of Extramural Acitivies, Executive Plaza South, Room 400C, 6120 Executive Blvd., Bethesda, MD 20892, 301–496–8683. (Catalogue of Federal Domestic Assistance Program Nos. 93.173, Biological Research Related to Deafness and Communicative Disorders, National Institutes of Health, HHS) Dated: January 14, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–1270 Filed 1–24–05; 8:45 am] Dated: January 14, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–1272 Filed 1–24–05; 8:45 am] BILLING CODE 4140–01–M BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. E:\FR\FM\25JAN1.SGM 25JAN1

Agencies

[Federal Register Volume 70, Number 15 (Tuesday, January 25, 2005)]
[Notices]
[Page 3536]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-1270]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institute of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Integrated Preclinical/Clinical 
AIDS Vaccine Development (PCAVD).
    Date: February 10-11, 2005.
    Time: 8:30 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: B. Duane Price, PhD., Scientific Review 
Administrator, Scientific Review Program, National Institute of 
Allergy & Infectious Diseases, DEA/NIH/DHHS, 6700B Rockledge Drive, 
Room 3147, Bethesda, MD 20892, (301) 451-2592, 
dbprice@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Review of an Unsolicited P01.
    Date: February 17, 2005.
    Time: 11 a.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge 6700, 6700B 
Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Thomas J. Hiltke, PhD., Scientific Review 
Administrator, Scientific Review Program, Divison of Extramural 
Activities, National Institutes of Health/NIAID, 6700 B Rockledge 
Drive, MSC 7616, Bethesda, MD 20892-7616, (301) 496-2550, 
thiltke@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, International Clinical Sciences 
Support.
    Date: February 18, 2005.
    Time: 9 a.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA 
22209.
    Contact Person: Marc L. Lesnick, PhD., Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, DHHS/National Institutes of Health/NIAID, 6700B 
Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, (301) 496-2550, 
ml436d@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 14, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-1270 Filed 1-24-05; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.